![](https://canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBcXNFIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--db7c73ffeac2dc4925d982cf8d1442cf7cf87e08/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/Logos.png)
Day One Biopharmaceuticals
Day One is rapidly developing novel cancer medicines for both children and adults living with cancer.
Website
dayonebio.comPartner
Julie GrantInvestment
Series A
Day One is rapidly developing novel cancer medicines for both children and adults living with cancer.
Series A